Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My NCBI Filters

Results by year

Table representation of search results timeline featuring number of search results per year.

Year Number of Results
1954 3
1968 1
1975 3
1980 1
1981 1
1982 1
1984 7
1985 1
1986 2
1988 4
1989 1
1990 3
1991 4
1992 3
1993 5
1994 5
1995 3
1996 6
1997 6
1998 6
1999 3
2000 7
2001 8
2002 8
2003 5
2004 7
2005 6
2006 7
2007 10
2008 9
2009 16
2010 15
2011 16
2012 17
2013 18
2014 19
2015 14
2016 15
2017 12
2018 20
2019 20
2020 22
2021 27
2022 33
2023 37
2024 8

Text availability

Article attribute

Article type

Publication date

Search Results

387 results

Results by year

Filters applied: . Clear all
Page 1
The New Era of Immunotherapy in Gastric Cancer.
Takei S, Kawazoe A, Shitara K. Takei S, et al. Cancers (Basel). 2022 Feb 18;14(4):1054. doi: 10.3390/cancers14041054. Cancers (Basel). 2022. PMID: 35205802 Free PMC article. Review.
Evidence-based clinical practice guideline for adult Still's disease.
Mimura T, Kondo Y, Ohta A, Iwamoto M, Ota A, Okamoto N, Kawaguchi Y, Kono H, Takasaki Y, Takei S, Nishimoto N, Fujimoto M, Asanuma YF, Mimori A, Okiyama N, Kaneko S, Takahashi H, Yokosawa M, Sumida T. Mimura T, et al. Among authors: takei s. Mod Rheumatol. 2018 Sep;28(5):736-757. doi: 10.1080/14397595.2018.1465633. Epub 2018 May 9. Mod Rheumatol. 2018. PMID: 29651907 Review.
Efficacy and safety of tocilizumab in patients with refractory Takayasu arteritis: results from a randomised, double-blind, placebo-controlled, phase 3 trial in Japan (the TAKT study).
Nakaoka Y, Isobe M, Takei S, Tanaka Y, Ishii T, Yokota S, Nomura A, Yoshida S, Nishimoto N. Nakaoka Y, et al. Among authors: takei s. Ann Rheum Dis. 2018 Mar;77(3):348-354. doi: 10.1136/annrheumdis-2017-211878. Epub 2017 Nov 30. Ann Rheum Dis. 2018. PMID: 29191819 Free PMC article. Clinical Trial.
Secondary Syphilis Rash.
Takei S, Suzuki K, Otsuka H, Watanabe S. Takei S, et al. JMA J. 2023 Oct 16;6(4):546-547. doi: 10.31662/jmaj.2023-0068. Epub 2023 Sep 13. JMA J. 2023. PMID: 37941701 Free PMC article. No abstract available.
Redox-regulated mechanisms in asthma.
Hoshino T, Okamoto M, Takei S, Sakazaki Y, Iwanaga T, Aizawa H. Hoshino T, et al. Among authors: takei s. Antioxid Redox Signal. 2008 Apr;10(4):769-83. doi: 10.1089/ars.2007.1936. Antioxid Redox Signal. 2008. PMID: 18179361 Review.
Dermatitis herpetiformis triggered by iodine contrast media.
Tsutsui Y, Hasegawa A, Uchida S, Terao K, Takei S, Yokoyama A, Sato A, Kabata Y, Hayashi R, Fujikawa H, Togashi K, Abe R. Tsutsui Y, et al. Among authors: takei s. J Eur Acad Dermatol Venereol. 2022 May;36(5):e348-e350. doi: 10.1111/jdv.17860. Epub 2021 Dec 20. J Eur Acad Dermatol Venereol. 2022. PMID: 34897819 No abstract available.
BMP4-SMAD1/5/9-RUNX2 pathway activation inhibits neurogenesis and oligodendrogenesis in Alzheimer's patients' iPSCs in senescence-related conditions.
Nakatsu D, Kunishige R, Taguchi Y, Shinozaki-Narikawa N, Osaka K, Yokomizo K, Ishida M, Takei S, Yamasaki S, Hagiya K, Hattori K, Tsukamoto T, Murata M, Kano F. Nakatsu D, et al. Among authors: takei s. Stem Cell Reports. 2023 Mar 14;18(3):688-705. doi: 10.1016/j.stemcr.2023.01.004. Epub 2023 Feb 9. Stem Cell Reports. 2023. PMID: 36764297 Free PMC article.
387 results